A Survey on Publication Standards of Medical Drug and Device Advertisements Published in Core Medical Journals in China_Chinese Journal of Evidence-Based Medicine

Authors：

1. Editorial Board of Chinese Journal of Evidence-Based Medicine, West China Hospital of Sichuan University, Chengdu 610041, China2. Chinese Evidence-Based Medicine Center, West China Hospital of Sichuan University, Chengdu 610041, China3. Department of Traditional Chinese Medicine, The 3nd People’s Hospital, Chengdu 610031, China4. West China School of Medicine, Sichuan University, Chengdu 610041, China;

Corresponding author：

Keywords：

Medical journal; Medical drug; Device; Advertisement; Publication standard; Investigation

DOI：

10.7507/1672-2531.20090210

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Objective 　To learn the current status, publication standards, formats, and contents of medical advertisements published in journals in China, and to discuss the possibility of evidence-based evaluation and standards for advertisement publication.
Methods 　We handsearched Issue One, 2008 of 222 core medical journals indexed by A Guide to the Core Journals of China (2004 version) and the most important databases to index top 20% academic journals to identify basic journal information and the content of their advertisements. The general and trade name of the drugs, and the advertisements and production license number of the drugs and devices were collected. We used EXCEL software for data input and SPSS 13.0 for statistical analyses.
Results 　Two-hundred and eighteen journals were handsearched and evaluated. The other 4 journals were excluded because the print version could not be found. A total of 1,201 advertisements were published in 159 (72.9%) of the journals, with the average of 5.5 (range of 1-37) for each journal. Of the advertisements, 910 (75.8%) were related to medical drugs or devices, including 598 (49.8%) drug and 312 (26.0%) medical device advertisements. Most of them were published in clinical and special medical journals. There were 518 (86.6%) drug advertisements which had both advertisement license and production license number, but only 116 (36.1%) medical device advertisements stated the advertisement license and production license number.
Conclusion 　The medical drug advertisements published in core medical journals in China lack sufficient publication standards, and medical device advertisements are even worse. We cannot conclude the efficacy, safety, and cost-effectiveness of advertisement production according to the current limited, unclear, and highly-commercialized advertisements.

Citation： DU Liang,CHEN Min,CHEN Yaolong,LI Jiaxin,LI Lin,ZHANG Qiongwen,WANG Haiqing,LIU Guanjian,LI Youping. A Survey on Publication Standards of Medical Drug and Device Advertisements Published in Core Medical Journals in China. Chinese Journal of Evidence-Based Medicine, 2009, 09(11): 1160-1164. doi: 10.7507/1672-2531.20090210 Copy

1.	杜云祥, 雷春炳, 陈建青, 等. 国内5大中文生物医学期刊数据库文献收录比较研究. 预防医学情报杂志, 2006, 22(2): 162-165.
2.	中国期刊医疗广告九成多涉嫌违法(10种期刊名单). http://www.chinanews.com.cn/n/2003-08-12/26/334276.html.
3.	韩亮. 医药广告如何突破严管. 医药世界, 2005, (9): 64.
4.	国家药监局: 少数人让药监系统蒙羞我们很痛心. http://www.jhfda.gov.cn/Article_Show.asp?ArticleID=359.
5.	国家食品药品监督管理局. 报纸药品广告违法率达90%. http://former.sfda.gov.cn/cmsweb/webportal/W3186/A64004762.html.
6.	周志新, 方红玲, 徐刚珍, 等. 医学期刊广告经营原则与策略. 编辑学报, 2005, 17(5): 367-368.
7.	《药品广告审查办法》（局令第27号）. http://www.sda.gov.cn/ WS01/CL0306/24527.html.
8.	中华人民共和国卫生部国家工商行政管理总局国家食品药品监督管理局令. http://www.sda.gov.cn/WS01/CL0059/37889.html.
9.	游苏宁. 应重视医学期刊广告的质量.中华医学杂志, 1995, 75(4): 251-252.
10.	李季秋, 游苏宁. 中华内科杂志广告刊用情况的剖析. 中华内科杂志, 2004, 43(7): 485-486.
11.	丁铁钢. 违法药品、医疗器械、保健食品广告的新形式及监管对策. 中国药事, 2008, 22(1): 26-28.
12.	胡天佑, 王舒. 互联网——违法药品广告的又一阵地. 上海医药, 2008, 29(4): 164-166.
13.	http://www.sda.gov.cn/WS01/CL0051/27557.html.
14.	Sackett DL, Straus SE, Richardson WS, et al. Evidence based medicine: how to practice and teach EBM. Churchill Livingstone; New York. 2000: 1.
15.	杨岫岩. 实践循证医学需要识别“循证广告”. 中华医学杂志, 2005, 85(18): 1290-1291.
16.	Gutknecht DR. Evidence-based advertising? A survey of four major journals. J Am Board Fam Pract, 2001, 14(3): 197-200.
17.	Tuffs HA. Only 6% of drug advertising material is supported by evidence. BMJ, 2004, 328: 485.

1. 杜云祥, 雷春炳, 陈建青, 等. 国内5大中文生物医学期刊数据库文献收录比较研究. 预防医学情报杂志, 2006, 22(2): 162-165.
2. 中国期刊医疗广告九成多涉嫌违法(10种期刊名单). http://www.chinanews.com.cn/n/2003-08-12/26/334276.html.
3. 韩亮. 医药广告如何突破严管. 医药世界, 2005, (9): 64.
4. 国家药监局: 少数人让药监系统蒙羞我们很痛心. http://www.jhfda.gov.cn/Article_Show.asp?ArticleID=359.
5. 国家食品药品监督管理局. 报纸药品广告违法率达90%. http://former.sfda.gov.cn/cmsweb/webportal/W3186/A64004762.html.
6. 周志新, 方红玲, 徐刚珍, 等. 医学期刊广告经营原则与策略. 编辑学报, 2005, 17(5): 367-368.
7. 《药品广告审查办法》（局令第27号）. http://www.sda.gov.cn/ WS01/CL0306/24527.html.
8. 中华人民共和国卫生部国家工商行政管理总局国家食品药品监督管理局令. http://www.sda.gov.cn/WS01/CL0059/37889.html.
9. 游苏宁. 应重视医学期刊广告的质量.中华医学杂志, 1995, 75(4): 251-252.
10. 李季秋, 游苏宁. 中华内科杂志广告刊用情况的剖析. 中华内科杂志, 2004, 43(7): 485-486.
11. 丁铁钢. 违法药品、医疗器械、保健食品广告的新形式及监管对策. 中国药事, 2008, 22(1): 26-28.
12. 胡天佑, 王舒. 互联网——违法药品广告的又一阵地. 上海医药, 2008, 29(4): 164-166.
13. http://www.sda.gov.cn/WS01/CL0051/27557.html.
14. Sackett DL, Straus SE, Richardson WS, et al. Evidence based medicine: how to practice and teach EBM. Churchill Livingstone; New York. 2000: 1.
15. 杨岫岩. 实践循证医学需要识别“循证广告”. 中华医学杂志, 2005, 85(18): 1290-1291.
16. Gutknecht DR. Evidence-based advertising? A survey of four major journals. J Am Board Fam Pract, 2001, 14(3): 197-200.
17. Tuffs HA. Only 6% of drug advertising material is supported by evidence. BMJ, 2004, 328: 485.

Chinese Journal of Evidence-Based Medicine

A Survey on Publication Standards of Medical Drug and Device Advertisements Published in Core Medical Journals in China

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content